Excellence in Research
Prof. Ioannis Toumpoulis is the Head of Research & Development of our team. He has shown abundant researching activities consistently from 1995 up to today (23 years), despite his young age. His efficacy in the research sector is considered very high, since he has over 100 announcements/presentations in international conferences and over 80 publications in international scientific peer-reviewed magazines.
He has received 26 awards and disctinctions for his work in Greek and International conferences, and he has received 8 scholarships.
Awards
Marquis Who’s Who in
Science and Engineering.
2006
Evarts A. Graham Memorial Traveling Fellowship 2007-2008
American Association for Thoracic Surgery, 2007.
Edward B. Diethrich Vascular Surgical Society International Traveling Fellow Award.
International Congress XXI Endovascular Interventions. Scottsdale, AZ, USA, 2008.
Marquis Who’s Who in The World.
2008
Award of the Best Research Study.
Study: “Myocardial Protection from Ischemia Reperfusion Injury with Mitochondrial Injection”. 8th National (Panhellenic) Meeting of Thoracic and Cardiovascular Surgeons, Athens, Greece, 2010
Best Oral Presentation Award.
Study: “Differential Expression of Collagen Type V and XI alpha-1 in Human Ascending Thoracic Aortic Aneurysms”. 5th International Meeting of the Onassis Cardiac Surgery Center, Athens, Greece, 2010.
Award of the Best Research Study in Lung Cancer.
Study: “Gene Expression of Collagen Type XI(alpha-1) in Patients with Non-small Cell Lung Cacer Correlates with Prognosis”. 20th National (Panhellenic) Meeting of Thoracic Diseases, Athens, Greece, 2011.
Stavros Niarchos International Guest Scholarship
American College of Surgeons, 2014.
History......
2007Research
The novel mechanism was discovered. It explains how an aneurysm is created and grows and at the same time makes a diagnostic blood test possible.2016Company establishment
2017Proof of concept
100 preliminary blood tests prove the concept of the novel mechanism.2018International Patent
We applied for acquiring an international patent regarding the novel mechanism that describes the way an aneurysm is created and grows. PCT/EP2018/062897.2018 - 2019Egg - Enter • Grow • Go
Participation in the Egg - Enter • Grow • Go program. Egg is a Corporate Social Responsibility initiative of Eurobank, designed and implemented with Corallia. It's one of the largest incubator and accelerator programs in Greece.2019Funding
Big Pi Ventures, a seed-stage and technology-transfer fund investing in Greece, member of EIF-Equifund, decided to invest in our company, and in our innovative and unique product.2020Growing
Moving towards CE Certification under the IVDR 2017/746 Regulation for the diagnostic blood test that detects the aortic aneurysm.
Our Team
Stavros Toumpoulis, DDS
Founder & President
Stavros is CEO and founder of 2bullMeDiTherapy, which was founded in 2016 with the purpose of offering a wide range of effective diagnostic and therapeutic solutions. Through modern research, technology and the discovery of innovative biological mechanisms we target the creation of new diagnostic blood tests which can detect diseases at an early stage when they are easier to be cured.
Also, our goal is to create diagnostic tests that can predict possible complications which may arise after thoracic surgery.
Graduate studies in Dental School of Aristoteles University Of Thessaloniki
Prof. Ioannis Toumpoulis
CSO & Vice President
Doctor Ioannis Toumpoulis has over 10 years of experience in cardiothoracic surgery. He has been an assistant Professor of Cardiothoracic Surgery at the National and Kapodistrian University of Athens for 7 years. Dr. Ioannis Toumpoulis has successfully completed two fellowships in the United States of America including one at Columbia University College of Physicians and Surgeons in new York, and one at Harvard Medical School in Boston, MA.
Dr. Ioannis Toumpoulis has been honored for his clinical and research studies with awards from the most prestigious American associations including the American Collage of Chest Physicians, the American Heart Association, the American Association for thoracic surgery and the American college of surgeons.
Christos Gkogkas
CTO
Dr Christos Gkogkas is a molecular/cellular neurobiologist, specialising in neuropsychiatric and neurodevelopmental disorders with over 15 years of academic research experience. He is a Group Leader at the Foundation of Research and Technology, Institute of Molecular Biology and Biotechnology, Biomedical Research, in Ioannina, Greece. Previously he was a Principal Investigator at the University of Edinburgh, UK and has carried out his postdoctoral training at McGill University, Canada. Christos focuses on the development of new technologies for IVDs.
He received a PhD in Molecular Neuroscience and an MSC in Neuroinformatics from the University of Edinburgh, UK and a BSc in Biology from the University of Athens, Greece.
Dimitris Kanistras
CEO